Clinical Trials Logo

Prenatal Diagnosis clinical trials

View clinical trials related to Prenatal Diagnosis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06239077 Recruiting - Genetics Clinical Trials

Identifai Genetics Analytic Validity Study - Compound Heterozygosity and Samples Collection

Start date: December 5, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to validate a noninvasive prenatal diagnosis procedure for genetic conditions in the developing fetus by analyzing fetal genetic material present in the pregnant mother's blood.

NCT ID: NCT04285814 Recruiting - Genetic Disease Clinical Trials

Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood

Start date: September 1, 2020
Phase:
Study type: Observational

Amniocentesis (amnio) and chorionic villus sampling (CVS) can reliably detect many smaller DNA/genetic abnormalities that cannot be reliably diagnosed by cell-free noninvasive prenatal testing (NIPT) that is in widespread use. The investigators present evidence that a cell-based form of NIPT, here called Single Fetal Cell (SFC) testing, using a blood sample from the mother can detect most or all of the genetic abnormalities that are detected using amnio or CVS. This study proposes to compare the effectiveness of SFC testing in detecting abnormalities already detected by amnio or CVS in women already undergoing these tests as part of their clinical care because of fetal ultrasound abnormalities.

NCT ID: NCT03201666 Recruiting - Prenatal Diagnosis Clinical Trials

Comparison of Karyotyping, CMA and NIPT for Prenatal Diagnosing Chromosomal Anomalies

Start date: July 1, 2016
Phase: N/A
Study type: Observational

This diagnostic test is aimed to compare the Karyotyping, CMA and NIPT for prenatal diagnosing chromosomal anomalies. Pregnant women who needed prenatal genetic diagnosis meted the study criterion; fetal amniotic fluid was regular examined by Karyotyping and CMA, and maternal peripheral blood was collected for NIPT detecting. And the CMA result as a golden standard, the main outcome is compared the diagnostic efficacy of NIPT for diagnosing chromosomal anomalies.

NCT ID: NCT02962830 Recruiting - Prenatal Diagnosis Clinical Trials

Sufentanil Pharmacokinetics After Intra Amniotic Injection

2IAS
Start date: April 19, 2017
Phase: Phase 2
Study type: Interventional

The fetus may be exposed during pregnancy to nociceptive stimuli because of fetal pathology (e.g., malformation) or a diagnostic or therapeutic procedure. To date, there is very little data and no consensus on fetal analgesia. The aim of the investigators study is to evaluate the pharmacokinetics of Sufentanil after intra amniotic injection.